RECRUITING

Generic Database of Very Low Birth Weight Infants

Description

The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and trends between baseline information, treatments, and infant outcome, and to develop future NRN trials.

Study Overview

Study Details

Study overview

The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and trends between baseline information, treatments, and infant outcome, and to develop future NRN trials.

Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants

Generic Database of Very Low Birth Weight Infants

Condition
Infant, Newborn
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Los Angeles

University of California - Los Angeles, Los Angeles, California, United States, 90025

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

San Diego

University of California at San Diego, San Diego, California, United States, 92103-8774

San Diego

Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States, 92123

New Haven

Yale University, New Haven, Connecticut, United States, 06504

Washington

George Washington University, Washington, District of Columbia, United States, 20052

Miami

University of Miami, Miami, Florida, United States, 33136

Atlanta

Emory University, Atlanta, Georgia, United States, 30303

Chicago

Northwestern Lurie Children's Hospital of Chicago, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Infants inborn at NICHD NRN centers that are:
  • * 401-1000 grams birth weight, and/or
  • * 20 0/7 to 28 6/7 weeks (\<29 weeks) gestational age
  • * Infants enrolled in one or more additional NICHD NRN interventional trials or time-limited observational studies. For infants that do not meet the inclusion criteria above, inclusion and exclusion criteria for the Generic Database are determined by the criteria for the additional trial(s). In these cases, infants that are larger than 1,000 grams and/or older than 29 weeks may be included in the GDB.
  • * Infants \>1,000 grams birth weight and/or \>29 weeks gestational age

Ages Eligible for Study

to 14 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NICHD Neonatal Research Network,

Abbot R Laptook, MD, PRINCIPAL_INVESTIGATOR, Brown University, Women & Infants Hospital of Rhode Island

Anna Maria Hibbs, MD, MSCE, FAAP, PRINCIPAL_INVESTIGATOR, Case Western Reserve University, Rainbow Babies and Children's Hospital

C. Michael Cotten, MD, PRINCIPAL_INVESTIGATOR, Duke University

Ravi M Patel, MD, MSc, STUDY_CHAIR, Emory University

Abhik Das, PhD, PRINCIPAL_INVESTIGATOR, RTI International

Krisa P Van Meurs, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Stephanie Merhar, MD MS, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati

Waldemar A Carlo, MD, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Tarah Colaizy, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Iowa

Kristi L Watterberg, MD, PRINCIPAL_INVESTIGATOR, University of New Mexico

Myra Wyckoff, MD, PRINCIPAL_INVESTIGATOR, University of Texas, Southwestern Medical Center at Dallas

Jon E Tyson, MD MPH, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Sara DeMauro, MD, MSCE, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Carl D'Angio, MD, PRINCIPAL_INVESTIGATOR, University of Rochester

Pablo Sanchez, MD, PRINCIPAL_INVESTIGATOR, Research Institute at Nationwide Children's Hospital

Robin Ohls, MD, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

2030-03-31